Analyst Coverage
| Firm | Analyst |
|---|---|
| Deutsche Bank | David M. Steinberg |
| Bank of America/Merrill Lynch | Gregg Gilbert |
| Ladenberg Thalmann | Matt Kaplan |
| Lazard Capital Markets | William Tanner, Ph.D |
| Leerink Swann | Joseph P. Schwartz |
| Wedbush Pac Grow Life Sciences | Liana Moussatos, Ph.D. |
MAP Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Stock Information
| NASDAQ:MAPP
$15.50 |
+ 0.63 |
| Mar 9, 2010 | 4:00 PM ET |
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Information provided by eSignal.